Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-EGFR and Anti-VEGF Molecules
Journal:
Current Drug Metabolism
Volume:
12
Page:
944-955
Author(s):
Michele Caraglia, Daniele Santini, Giuseppe Bronte, Sergio Rizzo, Giovanni Sortino, Giovam Battista Rini, Gaetana Di Fede and Antonio Russo
Alternative Spliced Variants as Biomarkers of Colorectal Cancer
Journal:
Current Drug Metabolism
Volume:
12
Page:
966-974
Author(s):
Qian Yi and Liling Tang
Genetic Surgery - A Right Strategy to Attack Cancer
Journal:
Current Gene Therapy
Volume:
11
Page:
501-531
Author(s):
Eugene D. Sverdlov
The Chemical Biology of Immunophilin Ligands
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
5355-5379
Author(s):
S. Gaali, R. Gopalakrishnan, Y. Wang, C. Kozany and F. Hausch
Inflammatory Mediators Hold the Key to Dendritic Cell Suppression and Tumor Progression
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
5507-5518
Author(s):
K. C. Sheng, M. D. Wright and V. Apostolopoulos
Left-Right Asymmetry in Embryonic Development and Breast Cancer: Common Molecular Determinants?
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
5519-5527
Author(s):
J. Wilting and M. Hagedorn
Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
5528-5544
Author(s):
D. A. Sabbah, M. G. Brattain and H. Zhong
Vascular Disrupting Agents (VDA) in Oncology: Advancing Towards New Therapeutic Paradigms in the Clinic
Journal:
Current Drug Targets
Volume:
12
Page:
2009-2015
Author(s):
Matthew A. Spear, Patricia LoRusso, Alain Mita and Monica Mita
The Pim Kinases: New Targets for Drug Development
Journal:
Current Drug Targets
Volume:
12
Page:
2059-2066
Author(s):
Ronan Swords, Kevin Kelly, Jennifer Carew, Stefan Nawrocki, Devalingam Mahalingam, John Sarantopoulos, David Bearss and Francis Giles
Targeting Mitochondria in Fighting Cancer
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
4034-4046
Author(s):
Vladimir Gogvadze